Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis
Clinical trial NCT05525520 · COMPLETED
Trial details
- NCT number
- NCT05525520
- Sponsor
- Escient Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-06
- Primary completion
- 2024-07-17
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.